1.Alternative Name：SLC39A6/ZIP6
2.Target:SLC39A6
3.Source:Human SLC39A6 was expressed from HEK293 with human IgG1 FC at the C-terminal
4.Sequence:Phe29-Trp325
5.Protein structure:Q13433hFC
6.Molecular Characterization:The protein has a calculated MW of 60kDa.The reducing (R) heterodimer protein migrates as 85-110 kDa due to glycosylation
7.Purity:SDS-PAGE>90%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
11.SDS-PAGE
Determined by SDS-PAGE, the purity of the protein is greater than 90%.
12.ELISA
When Recombinant Human SLC39A6（29-325） / hFC Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Anti-Human LIV-1 / SLC39A6(ladiratuzumab) that produces 50% of the optimal binding response is approximately 60ug/ml.
Note：For research use only .
...
产品展厅
